Anders Helander

10.6k total citations
226 papers, 7.7k citations indexed

About

Anders Helander is a scholar working on Pathology and Forensic Medicine, Toxicology and Epidemiology. According to data from OpenAlex, Anders Helander has authored 226 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pathology and Forensic Medicine, 75 papers in Toxicology and 46 papers in Epidemiology. Recurrent topics in Anders Helander's work include Alcohol Consumption and Health Effects (131 papers), Forensic Toxicology and Drug Analysis (75 papers) and Poisoning and overdose treatments (29 papers). Anders Helander is often cited by papers focused on Alcohol Consumption and Health Effects (131 papers), Forensic Toxicology and Drug Analysis (75 papers) and Poisoning and overdose treatments (29 papers). Anders Helander collaborates with scholars based in Sweden, United States and United Kingdom. Anders Helander's co-authors include Olof Beck, Matilda Bäckberg, Helen Dahl, Yufang Zheng, Jonas Bergström, Jan‐Olof Jeppsson, Alan Wayne Jones, Nikolai Stephanson, Stefan Borg and Olof Tottmar and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anders Helander

223 papers receiving 7.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Helander Sweden 52 4.1k 2.6k 2.0k 1.9k 896 226 7.7k
Giovanni Addolorato Italy 56 2.3k 0.6× 361 0.1× 998 0.5× 3.1k 1.6× 581 0.6× 247 8.9k
Frank Mußhoff Germany 42 991 0.2× 2.9k 1.1× 1.2k 0.6× 238 0.1× 747 0.8× 240 6.5k
Gisela Skopp Germany 36 1.1k 0.3× 2.0k 0.8× 644 0.3× 385 0.2× 395 0.4× 193 4.3k
Friedrich Martin Wurst Germany 36 2.0k 0.5× 883 0.3× 777 0.4× 1.0k 0.5× 317 0.4× 100 3.5k
Simona Pichini Italy 50 818 0.2× 3.1k 1.2× 1.3k 0.6× 500 0.3× 1.2k 1.4× 348 9.1k
Santo Davide Ferrara Italy 35 643 0.2× 1.3k 0.5× 683 0.3× 372 0.2× 389 0.4× 104 3.9k
Francesco Paolo Busardò Italy 40 588 0.1× 2.5k 0.9× 816 0.4× 290 0.2× 1.0k 1.2× 230 5.2k
Robert Kronstrand Sweden 39 924 0.2× 3.0k 1.1× 777 0.4× 263 0.1× 1.0k 1.1× 135 4.4k
Volker Auwärter Germany 45 1.5k 0.4× 4.4k 1.7× 1.0k 0.5× 217 0.1× 1.6k 1.7× 206 6.2k
Barry Levine United States 43 469 0.1× 2.0k 0.8× 1.0k 0.5× 298 0.2× 664 0.7× 195 5.8k

Countries citing papers authored by Anders Helander

Since Specialization
Citations

This map shows the geographic impact of Anders Helander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Helander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Helander more than expected).

Fields of papers citing papers by Anders Helander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Helander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Helander. The network helps show where Anders Helander may publish in the future.

Co-authorship network of co-authors of Anders Helander

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Helander. A scholar is included among the top collaborators of Anders Helander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Helander. Anders Helander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaz, Juan, Patrik Nasr, Anders Helander, et al.. (2025). Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes. Journal of Hepatology. 83(5). 1011–1022. 7 indexed citations
2.
Helander, Anders, Annika Andersson, & Tomás Villén. (2024). Alternative routine for reporting chiral amphetamine test results in assessment of attention‐deficit/hyperactivity disorder medication: experiences from 2013 to 2023. Drug Testing and Analysis. 17(1). 163–169. 1 indexed citations
3.
Helander, Anders, et al.. (2024). Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing – focus on HHC, HHC-P, HHC-O and HHC-H. Scandinavian Journal of Clinical and Laboratory Investigation. 84(2). 125–132. 7 indexed citations
4.
Helander, Anders, Matilda Bäckberg, & Olof Beck. (2020). Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLoS ONE. 15(4). e0232038–e0232038. 27 indexed citations
5.
Jannetto, Paul J., Anders Helander, Uttam Garg, et al.. (2018). The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry. 65(2). 242–253. 125 indexed citations
6.
Bergstrand, Madeleine Pettersson, Olof Beck, & Anders Helander. (2018). Urine analysis of 28 designer benzodiazepines by liquid chromatography–high-resolution mass spectrometry. PubMed. 10. 25–32. 16 indexed citations
7.
Schellenberg, François, Jos P.M. Wielders, Raymond F. Anton, et al.. (2016). IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use. Clinica Chimica Acta. 465. 91–100. 29 indexed citations
8.
Beck, Olof, et al.. (2014). Detectability of new psychoactive substances, ‘legal highs’, in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Testing and Analysis. 6(5). 492–499. 37 indexed citations
9.
Hultén, Peter, et al.. (2013). The impact of an MDPV-epidemic on a medium sized Swedish city. Clinical Toxicology. 51(4). 257–257. 3 indexed citations
10.
Comasco, Erika, et al.. (2012). Alcohol Consumption Among Pregnant Women in a Swedish Sample and Its Effects on the Newborn Outcomes. Alcoholism Clinical and Experimental Research. 36(10). 1779–1786. 48 indexed citations
11.
Snell, Lawrence D., Vijay A. Ramchandani, Laura Saba, et al.. (2011). The Biometric Measurement of Alcohol Consumption. Alcoholism Clinical and Experimental Research. 36(2). 332–341. 9 indexed citations
12.
Hultén, Peter, et al.. (2009). Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. Clinical Toxicology. 47(6). 566–572. 28 indexed citations
13.
Helander, Anders, Michael E. Böttcher, Christoph Fehr, Norbert Dahmen, & Olof Beck. (2008). Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification. Alcohol and Alcoholism. 44(1). 55–61. 171 indexed citations
15.
Helander, Anders & Jonas Bergström. (2006). Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test. Clinica Chimica Acta. 371(1-2). 187–190. 36 indexed citations
16.
Helander, Anders & Olof Beck. (2005). Ethyl Sulfate: A Metabolite of Ethanol in Humans and a Potential Biomarker of Acute Alcohol Intake. Journal of Analytical Toxicology. 29(5). 270–274. 118 indexed citations
17.
Eksborg, Staffan, et al.. (2005). Blood‐borne factors possibly associated with post‐operative nausea and vomiting: an explorative study in women after breast cancer surgery. Acta Anaesthesiologica Scandinavica. 49(9). 1346–1354. 17 indexed citations
18.
Dahl, Helen, Nikolai Stephanson, Olof Beck, & Anders Helander. (2002). Comparison of Urinary Excretion Characteristics of Ethanol and Ethyl Glucuronide. Journal of Analytical Toxicology. 26(4). 201–204. 160 indexed citations
19.
Helander, Anders & Alan Wayne Jones. (2000). Application of alcohol markers in traffic medicine. 2000. 2 indexed citations
20.
Helander, Anders & Sten Carlsson. (1990). Use of Leukocyte Aldehyde Dehydrogenase Activity to Monitor Inhibitory Effect of Disulfiram Treatment. Alcoholism Clinical and Experimental Research. 14(1). 48–52. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026